September 11th, 2014
Is This Trial Ethical?
CardioExchange Editors, Staff
Last month, an article appeared in The Telegraph (U.K.) describing a randomized trial in which cardiac arrest patients will be assigned to receive epinephrine or placebo during resuscitation.
Current ALCS guidelines contain a Class IIb, level A recommendation for administration of epinephrine for sustained VF and PEA/asystole but acknowledge that although epinephrine treatment has been demonstrated to increase rates of return of spontaneous circulation, it has not been shown to improve long-term survival.
This is not the first time epinephrine and placebo have been compared in a randomized trial; results of such a trial appeared in Resuscitation in 2011. Nonetheless, the new trial appears to have sparked ethical concerns about its delayed-consent procedure.
What do you think? Would you support such a trial in your EMS system?
Categories: General
Tags: advanced cardiac life support, cardiac arrest, epinephrine, informed consent, resuscitation
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.
-
NEJM Journal Watch — Recent Cardiology Articles
- Do GLP-1 Receptor Agonists Improve Walking Function in Patients with PAD and Claudication?
- Bleeding During Anticoagulation for Atrial Fibrillation and Subsequent Malignancy
- Revised Guidance for Athletes with Cardiovascular Disease: A Shift Toward Shared Decision Making
- Is a Traditional 5-to-7–Day Hold of Ticagrelor Necessary Prior to CABG?
- New Recommendations for Antithrombotic Therapy in Patients with Acute Coronary Syndromes
-
Sign up for NEJM Journal Watch Cardiology Alerts
Receive a free weekly email with the latest summaries on Cardiology.
-
Tag Cloud
- ACS AF AHA anticoagulation aortic valve replacement apixaban aspirin atrial fibrillation CABG cardiovascular risk cholesterol clopidogrel dabigatran diabetes diet drug-eluting stents epidemiology ESC exercise FDA FDA approvals Fellowship training guidelines HDL heart failure hypertension ICDs MI myocardial infarction obesity PCI Primary PCI risk factors rivaroxaban statins STEMI stents stroke stroke prevention TAVI TAVR type 2 diabetes venous thromboembolism warfarin women